Group Psychedelic-Assisted Therapy in the ACT

A future-focused, evidence-based mental health solution — led by ACT-trained professionals and supported by emerging science.

🔎 Why Now?

• ❌ Traditional Medicare sessions fall short: Short-term CBT doesn't meet the needs of people with complex trauma and depression.
  Watters et al., 2022 – MJA
• 📉 Mental health costs are rising: Group psychedelic therapy reduces burden on GPs and emergency departments.
  Schenberg, 2018 – Frontiers in Pharmacology
• 📆 Waitlists are at breaking point: System-wide modelling shows the current approach is unsustainable.
  Hall et al., 2022 – Australian Health Review

💡 What Makes Group Psychedelic Therapy Different?

• 🧠 Targets root causes, not symptoms: Promotes emotional breakthroughs in trauma-focused care.
  Ross et al., 2016 – J Psychopharm
• 🤝 Group formats amplify healing: Peer support, community connection, and cost efficiency.
  Wagner et al., 2021 – TAPP
• 🏥 Reduces pressure on the system: Safe, scalable, and locally deliverable in clinical settings.
  TGA Special Access Pathways

👩‍⚕️ Supported by ACT’s Mind Medicine–Trained Professionals

Psychiatrists, social workers, GPs, trauma counsellors and nurses in the ACT are trained, registered, and ready to deliver this care under TGA pathways.

🔎 Explore the national directory of trained practitioners:
Visit the Mind Medicine Australia Practitioner Directory →

💬 Find out more, ask questions, and help advance this innovative therapy model for those who need it most.